Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mycoplasma | 79 | 2001 | 139 | 3.700 |
Why?
|
Mycoplasma Infections | 60 | 2009 | 118 | 3.140 |
Why?
|
Ureaplasma urealyticum | 27 | 2016 | 38 | 2.770 |
Why?
|
Ureaplasma | 40 | 2016 | 59 | 2.270 |
Why?
|
Ureaplasma Infections | 17 | 2016 | 24 | 1.600 |
Why?
|
Pneumonia, Mycoplasma | 20 | 2009 | 50 | 1.460 |
Why?
|
Antigens, Bacterial | 29 | 2016 | 1171 | 1.200 |
Why?
|
Mycoplasmatales Infections | 17 | 1991 | 19 | 1.030 |
Why?
|
Mycoplasma pneumoniae | 15 | 2009 | 43 | 1.010 |
Why?
|
Rodent Diseases | 12 | 1995 | 57 | 0.570 |
Why?
|
Antibodies, Bacterial | 28 | 2016 | 1470 | 0.550 |
Why?
|
Rats, Inbred Lew | 19 | 1999 | 1162 | 0.500 |
Why?
|
Rats, Inbred F344 | 20 | 1995 | 862 | 0.480 |
Why?
|
Chorioamnionitis | 8 | 2009 | 155 | 0.470 |
Why?
|
Amniotic Fluid | 11 | 2009 | 370 | 0.440 |
Why?
|
Respiratory Tract Infections | 15 | 2002 | 961 | 0.430 |
Why?
|
Bronchopulmonary Dysplasia | 8 | 2003 | 306 | 0.430 |
Why?
|
Erythromycin | 9 | 1998 | 120 | 0.400 |
Why?
|
Bacterial Proteins | 14 | 2017 | 3848 | 0.350 |
Why?
|
Genes, Bacterial | 6 | 1996 | 1079 | 0.340 |
Why?
|
Drug Resistance, Microbial | 6 | 2001 | 862 | 0.340 |
Why?
|
Rats, Inbred Strains | 5 | 1989 | 2186 | 0.320 |
Why?
|
Amnion | 3 | 1995 | 209 | 0.320 |
Why?
|
Polymerase Chain Reaction | 13 | 2016 | 6171 | 0.310 |
Why?
|
DNA, Bacterial | 13 | 2016 | 1465 | 0.300 |
Why?
|
Genome, Bacterial | 3 | 2015 | 760 | 0.300 |
Why?
|
Pregnancy Complications, Infectious | 12 | 1993 | 2026 | 0.300 |
Why?
|
RNA, Ribosomal, 16S | 3 | 1996 | 954 | 0.300 |
Why?
|
Tuberculosis, Multidrug-Resistant | 5 | 2017 | 912 | 0.290 |
Why?
|
Scientific Misconduct | 1 | 2007 | 71 | 0.280 |
Why?
|
Mycoplasma hominis | 3 | 2009 | 9 | 0.280 |
Why?
|
Societies, Scientific | 3 | 1998 | 220 | 0.280 |
Why?
|
Communicable Diseases | 4 | 2001 | 880 | 0.270 |
Why?
|
Drug Evaluation | 1 | 2007 | 647 | 0.260 |
Why?
|
Tetracycline Resistance | 2 | 1997 | 20 | 0.260 |
Why?
|
Trachea | 12 | 1998 | 1076 | 0.260 |
Why?
|
Chorion | 2 | 1995 | 117 | 0.260 |
Why?
|
Antigens, Surface | 7 | 1989 | 1663 | 0.250 |
Why?
|
Mycoplasma fermentans | 3 | 1998 | 9 | 0.250 |
Why?
|
Rats | 42 | 2005 | 24260 | 0.240 |
Why?
|
Genital Diseases, Female | 6 | 1988 | 197 | 0.240 |
Why?
|
Chlamydia Infections | 7 | 2001 | 365 | 0.230 |
Why?
|
Obstetric Labor, Premature | 4 | 2009 | 279 | 0.230 |
Why?
|
Pneumonia, Bacterial | 3 | 2002 | 316 | 0.230 |
Why?
|
Antigenic Variation | 3 | 1994 | 125 | 0.220 |
Why?
|
Animals, Laboratory | 6 | 1988 | 51 | 0.210 |
Why?
|
Anti-Bacterial Agents | 10 | 2019 | 7181 | 0.210 |
Why?
|
Public Health Administration | 1 | 2004 | 240 | 0.210 |
Why?
|
Conflict of Interest | 1 | 2007 | 544 | 0.210 |
Why?
|
Leukocytes, Mononuclear | 1 | 2009 | 1836 | 0.200 |
Why?
|
Mice, Inbred C3H | 10 | 1998 | 964 | 0.200 |
Why?
|
Lung Diseases | 6 | 1998 | 1886 | 0.200 |
Why?
|
Pneumonia | 14 | 2009 | 2133 | 0.200 |
Why?
|
Species Specificity | 17 | 1998 | 2478 | 0.200 |
Why?
|
Lymphocyte Activation | 7 | 2009 | 5524 | 0.200 |
Why?
|
Lung | 21 | 2019 | 9856 | 0.190 |
Why?
|
Labor, Obstetric | 2 | 1995 | 333 | 0.190 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2004 | 501 | 0.190 |
Why?
|
Drug Industry | 1 | 2007 | 746 | 0.190 |
Why?
|
Respiratory System | 6 | 1999 | 557 | 0.190 |
Why?
|
Antitubercular Agents | 3 | 2019 | 1320 | 0.190 |
Why?
|
Drug Therapy | 2 | 2008 | 497 | 0.180 |
Why?
|
Bacteriological Techniques | 7 | 2010 | 277 | 0.180 |
Why?
|
Infant, Premature, Diseases | 3 | 1994 | 706 | 0.180 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 14 | 1998 | 3870 | 0.180 |
Why?
|
Capreomycin | 1 | 2019 | 14 | 0.180 |
Why?
|
Mycoplasma penetrans | 1 | 1999 | 2 | 0.170 |
Why?
|
Asthma | 4 | 2009 | 6011 | 0.170 |
Why?
|
Immunoenzyme Techniques | 5 | 2002 | 1799 | 0.170 |
Why?
|
Central Nervous System Diseases | 4 | 1993 | 518 | 0.160 |
Why?
|
Infant, Newborn | 31 | 2003 | 25625 | 0.160 |
Why?
|
Genital Diseases, Male | 3 | 1988 | 84 | 0.160 |
Why?
|
Fluoroquinolones | 2 | 1991 | 310 | 0.160 |
Why?
|
Endometritis | 2 | 1995 | 48 | 0.160 |
Why?
|
Immunologic Techniques | 2 | 2016 | 218 | 0.150 |
Why?
|
Biological Warfare | 2 | 1998 | 24 | 0.150 |
Why?
|
Bacteremia | 4 | 1999 | 962 | 0.150 |
Why?
|
Infant, Low Birth Weight | 6 | 1995 | 850 | 0.150 |
Why?
|
Animals | 88 | 2019 | 168757 | 0.150 |
Why?
|
Arthritis, Infectious | 5 | 1992 | 367 | 0.150 |
Why?
|
Molecular Weight | 8 | 1995 | 2255 | 0.150 |
Why?
|
Antiphospholipid Syndrome | 1 | 1999 | 173 | 0.150 |
Why?
|
Azepines | 1 | 2019 | 336 | 0.150 |
Why?
|
Chlamydia | 2 | 2001 | 33 | 0.150 |
Why?
|
Pulmonary Alveoli | 5 | 1995 | 675 | 0.150 |
Why?
|
Mycobacterium tuberculosis | 3 | 2017 | 1832 | 0.140 |
Why?
|
Microbiology | 2 | 1998 | 72 | 0.140 |
Why?
|
Cesarean Section | 2 | 1995 | 1365 | 0.140 |
Why?
|
RNA, Ribosomal, 23S | 1 | 1996 | 53 | 0.140 |
Why?
|
Academic Medical Centers | 1 | 2007 | 2759 | 0.140 |
Why?
|
Immunoglobulin M | 10 | 2009 | 1537 | 0.140 |
Why?
|
Serotyping | 5 | 2011 | 338 | 0.130 |
Why?
|
Molecular Sequence Data | 12 | 2012 | 18111 | 0.130 |
Why?
|
Infant, Premature | 6 | 2002 | 2044 | 0.130 |
Why?
|
RNA, Bacterial | 2 | 1996 | 390 | 0.130 |
Why?
|
Bacteriophages | 2 | 1988 | 356 | 0.120 |
Why?
|
Anti-Infective Agents | 3 | 1991 | 972 | 0.120 |
Why?
|
Pregnancy | 27 | 2011 | 29144 | 0.120 |
Why?
|
Tuberculosis | 2 | 2019 | 1912 | 0.120 |
Why?
|
Antibody Formation | 6 | 1989 | 1402 | 0.120 |
Why?
|
Gene Transfer, Horizontal | 2 | 2012 | 145 | 0.120 |
Why?
|
Base Sequence | 10 | 2000 | 12797 | 0.120 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 8 | 1991 | 1801 | 0.120 |
Why?
|
Doxycycline | 2 | 1992 | 326 | 0.120 |
Why?
|
Arteriosclerosis | 1 | 1998 | 1092 | 0.120 |
Why?
|
Clarithromycin | 4 | 2002 | 86 | 0.110 |
Why?
|
Introns | 1 | 1996 | 991 | 0.110 |
Why?
|
Latent Tuberculosis | 1 | 2015 | 225 | 0.110 |
Why?
|
Humans | 105 | 2019 | 744343 | 0.110 |
Why?
|
Fetal Membranes, Premature Rupture | 2 | 1992 | 140 | 0.110 |
Why?
|
Cell Wall | 1 | 2015 | 422 | 0.110 |
Why?
|
Spermatozoa | 2 | 1991 | 625 | 0.110 |
Why?
|
Immunity, Cellular | 4 | 2014 | 1607 | 0.110 |
Why?
|
Chlamydophila pneumoniae | 4 | 2002 | 55 | 0.110 |
Why?
|
Phylogeny | 3 | 1996 | 2803 | 0.110 |
Why?
|
Respiratory Tract Diseases | 3 | 1999 | 722 | 0.110 |
Why?
|
Mice | 43 | 2002 | 81183 | 0.110 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2017 | 567 | 0.110 |
Why?
|
Research | 2 | 2001 | 1999 | 0.100 |
Why?
|
Communicable Disease Control | 3 | 2006 | 857 | 0.100 |
Why?
|
Mice, Inbred Strains | 5 | 1996 | 1827 | 0.100 |
Why?
|
Immunoglobulin G | 12 | 2009 | 4560 | 0.100 |
Why?
|
Interleukin-6 | 3 | 2003 | 3200 | 0.100 |
Why?
|
Sexually Transmitted Diseases, Bacterial | 1 | 2011 | 24 | 0.100 |
Why?
|
Chemotactic Factors | 1 | 1992 | 199 | 0.100 |
Why?
|
Sperm-Ovum Interactions | 1 | 1991 | 24 | 0.100 |
Why?
|
Sequence Analysis, DNA | 4 | 2016 | 4803 | 0.100 |
Why?
|
Biomedical Research | 1 | 2007 | 3309 | 0.100 |
Why?
|
Female | 76 | 2015 | 380194 | 0.100 |
Why?
|
Alabama | 2 | 2007 | 98 | 0.100 |
Why?
|
Ciprofloxacin | 2 | 1991 | 315 | 0.100 |
Why?
|
Immunoblotting | 5 | 2016 | 1682 | 0.100 |
Why?
|
Antibody-Producing Cells | 2 | 1989 | 143 | 0.100 |
Why?
|
Fetal Diseases | 2 | 1995 | 903 | 0.090 |
Why?
|
Cross Reactions | 7 | 1990 | 841 | 0.090 |
Why?
|
Disease Models, Animal | 13 | 2007 | 18029 | 0.090 |
Why?
|
Microbial Sensitivity Tests | 7 | 1997 | 1877 | 0.090 |
Why?
|
Mycobacterium Infections | 1 | 1990 | 119 | 0.090 |
Why?
|
Community Health Services | 1 | 2015 | 650 | 0.090 |
Why?
|
Sperm Motility | 1 | 1991 | 253 | 0.090 |
Why?
|
Aerosols | 5 | 2019 | 625 | 0.090 |
Why?
|
Chemistry, Pharmaceutical | 2 | 2019 | 281 | 0.080 |
Why?
|
Gestational Age | 4 | 2002 | 3493 | 0.080 |
Why?
|
Lymphocytes | 7 | 1995 | 2617 | 0.080 |
Why?
|
Epitopes | 3 | 1996 | 2571 | 0.080 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 1989 | 80 | 0.080 |
Why?
|
Infertility, Female | 3 | 1983 | 787 | 0.080 |
Why?
|
Military Personnel | 1 | 1997 | 1133 | 0.080 |
Why?
|
Antigens, Protozoan | 1 | 1990 | 322 | 0.080 |
Why?
|
Thrombophlebitis | 1 | 1989 | 309 | 0.080 |
Why?
|
Antigen-Presenting Cells | 1 | 1992 | 973 | 0.080 |
Why?
|
Genetic Variation | 7 | 2011 | 6544 | 0.080 |
Why?
|
Fetal Death | 2 | 1993 | 448 | 0.080 |
Why?
|
Pulmonary Fibrosis | 1 | 1992 | 530 | 0.080 |
Why?
|
Recombination, Genetic | 2 | 2011 | 1586 | 0.080 |
Why?
|
Acholeplasma laidlawii | 1 | 1987 | 3 | 0.080 |
Why?
|
Hydrocephalus | 2 | 1991 | 748 | 0.080 |
Why?
|
Inflammation | 4 | 2014 | 10638 | 0.080 |
Why?
|
Hospitalization | 3 | 2015 | 10262 | 0.080 |
Why?
|
Protein C | 1 | 2007 | 138 | 0.080 |
Why?
|
B-Lymphocytes | 5 | 1993 | 4665 | 0.070 |
Why?
|
Azithromycin | 2 | 1998 | 196 | 0.070 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 1988 | 214 | 0.070 |
Why?
|
Nasopharynx | 3 | 1988 | 379 | 0.070 |
Why?
|
Mast Cells | 2 | 2005 | 1544 | 0.070 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 1996 | 1085 | 0.070 |
Why?
|
Male | 48 | 2019 | 350118 | 0.070 |
Why?
|
Multiple Trauma | 1 | 1989 | 367 | 0.070 |
Why?
|
Quinolones | 1 | 1989 | 367 | 0.070 |
Why?
|
RNA Viruses | 1 | 1987 | 124 | 0.070 |
Why?
|
Sternum | 1 | 1987 | 177 | 0.070 |
Why?
|
Chronic Disease | 11 | 2002 | 9146 | 0.070 |
Why?
|
Respirovirus | 2 | 1999 | 31 | 0.070 |
Why?
|
Public Sector | 1 | 2007 | 265 | 0.060 |
Why?
|
Societies, Medical | 1 | 1997 | 3743 | 0.060 |
Why?
|
Histocompatibility Antigens Class II | 2 | 1989 | 1475 | 0.060 |
Why?
|
Disease Susceptibility | 6 | 1992 | 1782 | 0.060 |
Why?
|
Adhesins, Bacterial | 1 | 2005 | 119 | 0.060 |
Why?
|
Urinary Tract Infections | 3 | 1987 | 788 | 0.060 |
Why?
|
Ebolavirus | 1 | 2007 | 263 | 0.060 |
Why?
|
Genitalia, Female | 2 | 1986 | 146 | 0.060 |
Why?
|
Intrauterine Devices, Copper | 1 | 1984 | 32 | 0.060 |
Why?
|
DNA Primers | 3 | 2010 | 2892 | 0.060 |
Why?
|
Antibodies, Monoclonal | 5 | 2016 | 9274 | 0.060 |
Why?
|
Chlamydia trachomatis | 4 | 2001 | 246 | 0.060 |
Why?
|
Interleukin-4 | 2 | 2005 | 1147 | 0.060 |
Why?
|
Agammaglobulinemia | 1 | 1985 | 167 | 0.060 |
Why?
|
Culture Media | 4 | 1991 | 908 | 0.060 |
Why?
|
Private Sector | 1 | 2007 | 392 | 0.060 |
Why?
|
Oligonucleotide Probes | 3 | 2010 | 427 | 0.060 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 1996 | 798 | 0.060 |
Why?
|
Papio | 2 | 2003 | 656 | 0.060 |
Why?
|
Opportunistic Infections | 1 | 1986 | 389 | 0.060 |
Why?
|
Antigens, Heterophile | 1 | 1983 | 69 | 0.060 |
Why?
|
Urogenital System | 2 | 1993 | 86 | 0.060 |
Why?
|
DNA Transposable Elements | 1 | 1987 | 748 | 0.060 |
Why?
|
Vaginitis | 1 | 1983 | 47 | 0.060 |
Why?
|
Adolescent | 15 | 2011 | 85781 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 1986 | 986 | 0.060 |
Why?
|
Respirovirus Infections | 2 | 1999 | 50 | 0.050 |
Why?
|
Maternal-Fetal Exchange | 3 | 1993 | 456 | 0.050 |
Why?
|
Immunization | 3 | 1987 | 1256 | 0.050 |
Why?
|
Anemia, Sickle Cell | 1 | 1991 | 1018 | 0.050 |
Why?
|
Government Regulation | 1 | 2007 | 522 | 0.050 |
Why?
|
Immunoglobulin A | 6 | 1999 | 992 | 0.050 |
Why?
|
Microscopy, Electron | 4 | 2002 | 2645 | 0.050 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2007 | 428 | 0.050 |
Why?
|
Vagina | 3 | 2001 | 825 | 0.050 |
Why?
|
Epidemiology | 1 | 2004 | 287 | 0.050 |
Why?
|
Cats | 2 | 1996 | 998 | 0.050 |
Why?
|
Diffusion of Innovation | 1 | 2007 | 725 | 0.050 |
Why?
|
Bronchi | 4 | 1998 | 840 | 0.050 |
Why?
|
Prospective Studies | 12 | 2015 | 53288 | 0.050 |
Why?
|
Surgical Wound Infection | 2 | 1990 | 1540 | 0.050 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2002 | 428 | 0.050 |
Why?
|
Interferon-gamma | 2 | 2009 | 3206 | 0.050 |
Why?
|
Germ-Free Life | 3 | 1992 | 188 | 0.050 |
Why?
|
Virulence | 3 | 1993 | 1333 | 0.050 |
Why?
|
Xenobiotics | 1 | 2001 | 73 | 0.050 |
Why?
|
Integrase Inhibitors | 1 | 2000 | 12 | 0.050 |
Why?
|
Peptide Hydrolases | 1 | 1984 | 634 | 0.050 |
Why?
|
Cross Infection | 1 | 1990 | 1416 | 0.050 |
Why?
|
Rabbits | 4 | 1996 | 4894 | 0.050 |
Why?
|
Macrophages | 8 | 1992 | 5655 | 0.050 |
Why?
|
Endometrium | 1 | 1983 | 424 | 0.050 |
Why?
|
Dendritic Cells | 1 | 1992 | 2725 | 0.050 |
Why?
|
Bronchial Hyperreactivity | 1 | 2002 | 319 | 0.050 |
Why?
|
Clindamycin | 2 | 1991 | 139 | 0.050 |
Why?
|
Blood | 3 | 1989 | 598 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2003 | 690 | 0.050 |
Why?
|
Adult | 26 | 2015 | 214055 | 0.050 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2000 | 65 | 0.050 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2000 | 102 | 0.050 |
Why?
|
Airway Resistance | 1 | 2001 | 404 | 0.050 |
Why?
|
Parainfluenza Virus 1, Human | 2 | 1998 | 28 | 0.050 |
Why?
|
Culture Techniques | 2 | 1995 | 554 | 0.050 |
Why?
|
Vaginosis, Bacterial | 1 | 2001 | 128 | 0.040 |
Why?
|
Uganda | 1 | 2004 | 1243 | 0.040 |
Why?
|
Dry Powder Inhalers | 1 | 2019 | 5 | 0.040 |
Why?
|
Infertility, Male | 1 | 1983 | 409 | 0.040 |
Why?
|
Cooperative Behavior | 1 | 2007 | 1504 | 0.040 |
Why?
|
Urethritis | 2 | 1993 | 23 | 0.040 |
Why?
|
Trichomonas vaginalis | 2 | 2001 | 76 | 0.040 |
Why?
|
Bacterial Adhesion | 2 | 1993 | 316 | 0.040 |
Why?
|
Macrophages, Alveolar | 1 | 2002 | 407 | 0.040 |
Why?
|
Membrane Proteins | 3 | 1992 | 7880 | 0.040 |
Why?
|
Cervix Uteri | 1 | 1983 | 590 | 0.040 |
Why?
|
Powders | 1 | 2019 | 80 | 0.040 |
Why?
|
Tetracycline | 3 | 1991 | 214 | 0.040 |
Why?
|
Bacterial Vaccines | 2 | 1998 | 403 | 0.040 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2002 | 406 | 0.040 |
Why?
|
Respiratory Function Tests | 1 | 2003 | 1616 | 0.040 |
Why?
|
Cytokines | 3 | 2005 | 7322 | 0.040 |
Why?
|
World Health Organization | 1 | 2004 | 1318 | 0.040 |
Why?
|
Cilia | 2 | 1993 | 466 | 0.040 |
Why?
|
Uterus | 1 | 1983 | 711 | 0.040 |
Why?
|
Antibiotics, Antitubercular | 1 | 2019 | 104 | 0.040 |
Why?
|
Infant | 11 | 2011 | 35136 | 0.040 |
Why?
|
Isoelectric Point | 2 | 1988 | 80 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 1984 | 1072 | 0.040 |
Why?
|
Immunosorbent Techniques | 2 | 1988 | 184 | 0.040 |
Why?
|
Binding, Competitive | 2 | 1990 | 1157 | 0.040 |
Why?
|
Bronchoalveolar Lavage Fluid | 4 | 2002 | 768 | 0.040 |
Why?
|
Mucociliary Clearance | 2 | 1988 | 67 | 0.040 |
Why?
|
Nose | 4 | 1999 | 509 | 0.040 |
Why?
|
Administration, Inhalation | 2 | 2019 | 1105 | 0.040 |
Why?
|
Meningitis | 2 | 1991 | 216 | 0.040 |
Why?
|
South Africa | 2 | 2015 | 1731 | 0.040 |
Why?
|
Naval Medicine | 1 | 1997 | 31 | 0.040 |
Why?
|
Integrases | 1 | 2000 | 533 | 0.040 |
Why?
|
Specific Pathogen-Free Organisms | 3 | 1995 | 226 | 0.040 |
Why?
|
Sensitivity and Specificity | 4 | 2010 | 14722 | 0.040 |
Why?
|
Guinea Pigs | 1 | 2019 | 1386 | 0.040 |
Why?
|
Nucleic Acid Conformation | 2 | 2000 | 913 | 0.040 |
Why?
|
Catalase | 1 | 2017 | 222 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 1997 | 252 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 6 | 1986 | 2505 | 0.030 |
Why?
|
Coronavirus, Rat | 1 | 1995 | 1 | 0.030 |
Why?
|
Postpartum Period | 2 | 1997 | 1086 | 0.030 |
Why?
|
Spleen | 5 | 1998 | 2362 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2002 | 4420 | 0.030 |
Why?
|
Information Services | 1 | 1997 | 244 | 0.030 |
Why?
|
Erythromycin Ethylsuccinate | 1 | 1995 | 1 | 0.030 |
Why?
|
Psychiatry | 1 | 2008 | 1695 | 0.030 |
Why?
|
Paramyxoviridae Infections | 1 | 1995 | 55 | 0.030 |
Why?
|
Prevalence | 2 | 2011 | 15226 | 0.030 |
Why?
|
Epitope Mapping | 1 | 1996 | 311 | 0.030 |
Why?
|
Birds | 1 | 1996 | 163 | 0.030 |
Why?
|
Consensus Sequence | 1 | 1996 | 377 | 0.030 |
Why?
|
DNA, Ribosomal | 2 | 1993 | 290 | 0.030 |
Why?
|
Isoniazid | 1 | 2017 | 274 | 0.030 |
Why?
|
Trial of Labor | 1 | 1995 | 80 | 0.030 |
Why?
|
Antibody Specificity | 3 | 1986 | 1095 | 0.030 |
Why?
|
Chlorides | 1 | 1998 | 667 | 0.030 |
Why?
|
Rifampin | 1 | 2017 | 315 | 0.030 |
Why?
|
Fibrosis | 1 | 2002 | 2029 | 0.030 |
Why?
|
Arthritis, Rheumatoid | 2 | 1981 | 3712 | 0.030 |
Why?
|
Particle Size | 1 | 2019 | 1642 | 0.030 |
Why?
|
Antipsychotic Agents | 1 | 2008 | 3057 | 0.030 |
Why?
|
Biological Evolution | 1 | 2000 | 1076 | 0.030 |
Why?
|
Whooping Cough | 1 | 1995 | 82 | 0.030 |
Why?
|
Child | 10 | 2011 | 77709 | 0.030 |
Why?
|
Radiography | 2 | 1997 | 7023 | 0.030 |
Why?
|
Nasal Mucosa | 2 | 1988 | 373 | 0.030 |
Why?
|
Labor, Induced | 1 | 1995 | 146 | 0.030 |
Why?
|
Education | 1 | 1997 | 543 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2000 | 2025 | 0.030 |
Why?
|
Escherichia coli | 4 | 2016 | 4217 | 0.030 |
Why?
|
Australia | 1 | 1997 | 1170 | 0.030 |
Why?
|
Hyaline Membrane Disease | 1 | 1993 | 19 | 0.030 |
Why?
|
Uterine Cervicitis | 1 | 1993 | 30 | 0.030 |
Why?
|
Socioeconomic Factors | 3 | 2006 | 7785 | 0.030 |
Why?
|
Immunoglobulins | 3 | 1989 | 881 | 0.030 |
Why?
|
Pharynx | 3 | 1998 | 413 | 0.030 |
Why?
|
Forecasting | 2 | 2001 | 2951 | 0.030 |
Why?
|
Double-Blind Method | 4 | 2002 | 12026 | 0.030 |
Why?
|
Epithelium | 3 | 1991 | 1679 | 0.030 |
Why?
|
Abscess | 1 | 1997 | 607 | 0.030 |
Why?
|
Respiratory Syncytial Viruses | 2 | 1998 | 165 | 0.030 |
Why?
|
California | 1 | 1997 | 1402 | 0.030 |
Why?
|
Japan | 1 | 1997 | 1360 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2009 | 10481 | 0.030 |
Why?
|
Genomics | 2 | 2017 | 5720 | 0.030 |
Why?
|
Ethics | 1 | 1992 | 94 | 0.030 |
Why?
|
Pneumonia, Pneumocystis | 2 | 1987 | 249 | 0.030 |
Why?
|
Actinomycosis | 1 | 1972 | 21 | 0.030 |
Why?
|
Postoperative Complications | 1 | 1995 | 15295 | 0.030 |
Why?
|
Tracheal Diseases | 1 | 1993 | 113 | 0.030 |
Why?
|
Cerebrospinal Fluid | 2 | 1995 | 534 | 0.030 |
Why?
|
Actinomyces | 1 | 1972 | 39 | 0.030 |
Why?
|
Polyethylene Glycols | 2 | 1989 | 1182 | 0.030 |
Why?
|
Role | 1 | 1992 | 175 | 0.030 |
Why?
|
Sodium | 1 | 1998 | 1623 | 0.030 |
Why?
|
Peptostreptococcus | 1 | 1992 | 27 | 0.030 |
Why?
|
Mice, Inbred C57BL | 7 | 1998 | 21827 | 0.030 |
Why?
|
Lung Compliance | 1 | 1992 | 195 | 0.030 |
Why?
|
Amino Acid Sequence | 4 | 2000 | 13815 | 0.030 |
Why?
|
Iron | 1 | 2000 | 1774 | 0.030 |
Why?
|
Immunity | 1 | 1978 | 1012 | 0.030 |
Why?
|
Fusobacterium | 1 | 1992 | 54 | 0.030 |
Why?
|
Macaca mulatta | 2 | 2009 | 2375 | 0.030 |
Why?
|
HIV Infections | 3 | 2015 | 16718 | 0.030 |
Why?
|
Dog Diseases | 1 | 1972 | 138 | 0.030 |
Why?
|
Plethysmography | 2 | 2002 | 180 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1991 | 279 | 0.020 |
Why?
|
Seasons | 1 | 1997 | 1493 | 0.020 |
Why?
|
Cough | 1 | 1995 | 555 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1993 | 964 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2016 | 1730 | 0.020 |
Why?
|
Erythrocytes | 3 | 1988 | 2455 | 0.020 |
Why?
|
Leukocyte Count | 2 | 1987 | 1588 | 0.020 |
Why?
|
Reference Standards | 1 | 1995 | 1025 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 2 | 1989 | 370 | 0.020 |
Why?
|
Age Factors | 3 | 2003 | 18370 | 0.020 |
Why?
|
Protozoan Infections | 1 | 1990 | 39 | 0.020 |
Why?
|
Career Mobility | 1 | 1993 | 262 | 0.020 |
Why?
|
Bacteroides fragilis | 1 | 1992 | 212 | 0.020 |
Why?
|
Neutrophils | 2 | 2002 | 3719 | 0.020 |
Why?
|
Lactobacillus | 1 | 1992 | 189 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1993 | 1681 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 1984 | 2861 | 0.020 |
Why?
|
DNA, Single-Stranded | 1 | 1992 | 354 | 0.020 |
Why?
|
T-Lymphocytes | 3 | 1986 | 10180 | 0.020 |
Why?
|
Mammals | 1 | 1996 | 1143 | 0.020 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 1991 | 189 | 0.020 |
Why?
|
Phenotype | 3 | 1993 | 16365 | 0.020 |
Why?
|
Gene Dosage | 1 | 1995 | 1252 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 1994 | 976 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2009 | 39050 | 0.020 |
Why?
|
Thalassemia | 1 | 1991 | 273 | 0.020 |
Why?
|
Cattle | 1 | 1996 | 3922 | 0.020 |
Why?
|
Octoxynol | 1 | 1989 | 77 | 0.020 |
Why?
|
Pregnancy Trimester, Second | 2 | 2001 | 732 | 0.020 |
Why?
|
Kinetics | 4 | 2000 | 6473 | 0.020 |
Why?
|
Mice, Inbred BALB C | 4 | 2002 | 6386 | 0.020 |
Why?
|
Neoplasms | 2 | 1998 | 21683 | 0.020 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 1989 | 131 | 0.020 |
Why?
|
Lymphoid Tissue | 2 | 1999 | 455 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1995 | 4320 | 0.020 |
Why?
|
Time Factors | 6 | 1992 | 40075 | 0.020 |
Why?
|
Confidence Intervals | 1 | 1995 | 2971 | 0.020 |
Why?
|
Pennsylvania | 1 | 1990 | 613 | 0.020 |
Why?
|
United States | 5 | 2007 | 69872 | 0.020 |
Why?
|
Ventriculostomy | 1 | 1990 | 136 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 1994 | 2274 | 0.020 |
Why?
|
Vaccination | 1 | 1981 | 3278 | 0.020 |
Why?
|
Risk Factors | 6 | 1997 | 72290 | 0.020 |
Why?
|
Mycobacterium | 1 | 1990 | 249 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2014 | 789 | 0.020 |
Why?
|
Child, Preschool | 6 | 2011 | 41006 | 0.020 |
Why?
|
Sputum | 1 | 1991 | 476 | 0.020 |
Why?
|
Breeding | 1 | 1988 | 51 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 1992 | 927 | 0.020 |
Why?
|
Computational Biology | 1 | 2001 | 3521 | 0.020 |
Why?
|
Vaginal Diseases | 1 | 1989 | 102 | 0.020 |
Why?
|
Trypsin | 1 | 1989 | 511 | 0.020 |
Why?
|
Genetics, Microbial | 2 | 1987 | 60 | 0.020 |
Why?
|
Virulence Factors | 1 | 2012 | 509 | 0.020 |
Why?
|
Home Care Services | 1 | 2015 | 606 | 0.020 |
Why?
|
Adsorption | 1 | 1988 | 201 | 0.020 |
Why?
|
Attitude | 1 | 1993 | 776 | 0.020 |
Why?
|
Receptors, Fc | 1 | 1992 | 541 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 1999 | 3176 | 0.020 |
Why?
|
Hydrolysis | 1 | 1989 | 682 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2002 | 77449 | 0.020 |
Why?
|
Peptides | 1 | 2000 | 4409 | 0.020 |
Why?
|
Peritoneum | 1 | 1989 | 228 | 0.020 |
Why?
|
Incidence | 2 | 1997 | 20947 | 0.020 |
Why?
|
Prenatal Diagnosis | 1 | 1995 | 1236 | 0.020 |
Why?
|
Cytomegalovirus Infections | 2 | 1987 | 820 | 0.020 |
Why?
|
Immunoelectrophoresis | 1 | 1987 | 110 | 0.020 |
Why?
|
Brain Diseases | 1 | 1997 | 1563 | 0.020 |
Why?
|
Hospitals, Community | 1 | 1990 | 348 | 0.020 |
Why?
|
Macrophage Activation | 1 | 1990 | 558 | 0.020 |
Why?
|
Virus Cultivation | 1 | 1987 | 92 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 1995 | 2126 | 0.020 |
Why?
|
Transformation, Bacterial | 1 | 1987 | 78 | 0.020 |
Why?
|
Analysis of Variance | 2 | 1995 | 6365 | 0.020 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 1 | 1987 | 33 | 0.020 |
Why?
|
Membranes | 1 | 1987 | 173 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1990 | 903 | 0.020 |
Why?
|
Infertility | 2 | 1986 | 655 | 0.020 |
Why?
|
Nitrogen Dioxide | 1 | 1989 | 490 | 0.020 |
Why?
|
Cell Fractionation | 1 | 1987 | 252 | 0.020 |
Why?
|
Acute Disease | 1 | 1997 | 7149 | 0.020 |
Why?
|
Immunization, Passive | 2 | 1999 | 623 | 0.020 |
Why?
|
Hemolysis | 1 | 1988 | 420 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1991 | 2557 | 0.020 |
Why?
|
DNA | 1 | 2000 | 7301 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2017 | 4328 | 0.020 |
Why?
|
Immune Sera | 2 | 1984 | 641 | 0.020 |
Why?
|
Klebsiella Infections | 1 | 1987 | 138 | 0.020 |
Why?
|
Cell Separation | 1 | 1992 | 1751 | 0.020 |
Why?
|
Uterine Diseases | 1 | 1987 | 135 | 0.020 |
Why?
|
Ovarian Diseases | 1 | 1987 | 139 | 0.020 |
Why?
|
RNA, Double-Stranded | 1 | 1987 | 290 | 0.020 |
Why?
|
Phagocytosis | 3 | 1980 | 1539 | 0.020 |
Why?
|
Oxygen Inhalation Therapy | 1 | 1988 | 367 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1987 | 1375 | 0.020 |
Why?
|
Education, Medical | 1 | 1997 | 1721 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2014 | 1477 | 0.020 |
Why?
|
Regression Analysis | 1 | 1995 | 6459 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 1985 | 448 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 1990 | 1179 | 0.020 |
Why?
|
Virion | 1 | 1987 | 433 | 0.020 |
Why?
|
Adhesiveness | 2 | 1981 | 53 | 0.020 |
Why?
|
Primates | 1 | 2007 | 545 | 0.020 |
Why?
|
Faculty, Medical | 1 | 1993 | 1181 | 0.020 |
Why?
|
Hemagglutination | 1 | 1984 | 34 | 0.020 |
Why?
|
Birth Weight | 2 | 1993 | 2069 | 0.020 |
Why?
|
Staphylococcal Protein A | 1 | 1984 | 40 | 0.020 |
Why?
|
Hot Temperature | 2 | 1989 | 1354 | 0.010 |
Why?
|
Collagen | 1 | 1992 | 2689 | 0.010 |
Why?
|
Electrophoresis | 1 | 1983 | 240 | 0.010 |
Why?
|
Amniocentesis | 1 | 1983 | 116 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 1992 | 1912 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1989 | 3129 | 0.010 |
Why?
|
Osteomyelitis | 1 | 1987 | 402 | 0.010 |
Why?
|
Ear, Middle | 1 | 1985 | 334 | 0.010 |
Why?
|
Osmolar Concentration | 2 | 2000 | 683 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2012 | 1940 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3597 | 0.010 |
Why?
|
Bone Marrow | 2 | 1990 | 2948 | 0.010 |
Why?
|
Sterilization, Tubal | 1 | 1983 | 87 | 0.010 |
Why?
|
Urethral Diseases | 1 | 1983 | 53 | 0.010 |
Why?
|
Catheterization, Central Venous | 1 | 2007 | 514 | 0.010 |
Why?
|
Drug Design | 1 | 2008 | 1076 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2015 | 3589 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 1993 | 2795 | 0.010 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2002 | 53 | 0.010 |
Why?
|
Laboratories | 1 | 2006 | 463 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1986 | 2327 | 0.010 |
Why?
|
Lymph Nodes | 2 | 1989 | 3474 | 0.010 |
Why?
|
Oligopeptides | 1 | 2007 | 1189 | 0.010 |
Why?
|
Blood Proteins | 1 | 1987 | 1124 | 0.010 |
Why?
|
Blotting, Western | 1 | 1989 | 5179 | 0.010 |
Why?
|
Infant Mortality | 1 | 1986 | 754 | 0.010 |
Why?
|
Plasmids | 1 | 1987 | 2307 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 1989 | 2216 | 0.010 |
Why?
|
Animals, Newborn | 3 | 1993 | 2726 | 0.010 |
Why?
|
Protein Conformation | 1 | 1989 | 4011 | 0.010 |
Why?
|
Cell Degranulation | 1 | 2002 | 287 | 0.010 |
Why?
|
Laparoscopy | 2 | 1983 | 2151 | 0.010 |
Why?
|
RNA, Messenger | 3 | 2005 | 13033 | 0.010 |
Why?
|
Middle Aged | 5 | 2011 | 213383 | 0.010 |
Why?
|
Integration Host Factors | 1 | 2000 | 13 | 0.010 |
Why?
|
Attachment Sites, Microbiological | 1 | 2000 | 26 | 0.010 |
Why?
|
Bacteriophage T4 | 1 | 2000 | 33 | 0.010 |
Why?
|
Newcastle disease virus | 1 | 1980 | 23 | 0.010 |
Why?
|
Interferon Inducers | 1 | 1980 | 25 | 0.010 |
Why?
|
Pinocytosis | 1 | 1980 | 65 | 0.010 |
Why?
|
Bacteriophage lambda | 1 | 2000 | 147 | 0.010 |
Why?
|
DNA, Superhelical | 1 | 2000 | 50 | 0.010 |
Why?
|
Cohort Studies | 2 | 2015 | 40561 | 0.010 |
Why?
|
DNA Restriction Enzymes | 1 | 2000 | 570 | 0.010 |
Why?
|
Colony-Forming Units Assay | 1 | 1980 | 356 | 0.010 |
Why?
|
Sonication | 1 | 1980 | 83 | 0.010 |
Why?
|
Vaccinia | 1 | 2000 | 76 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1992 | 2104 | 0.010 |
Why?
|
Joints | 1 | 1981 | 326 | 0.010 |
Why?
|
Inhibitory Concentration 50 | 1 | 2000 | 459 | 0.010 |
Why?
|
Fever | 1 | 1987 | 1616 | 0.010 |
Why?
|
Rubulavirus Infections | 1 | 1998 | 2 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2015 | 4256 | 0.010 |
Why?
|
Parainfluenza Virus 2, Human | 1 | 1998 | 8 | 0.010 |
Why?
|
Immunodiffusion | 2 | 1980 | 163 | 0.010 |
Why?
|
Parainfluenza Virus 3, Human | 1 | 1998 | 24 | 0.010 |
Why?
|
Oxygen | 1 | 1990 | 4189 | 0.010 |
Why?
|
Otitis | 1 | 1978 | 20 | 0.010 |
Why?
|
Hyperplasia | 1 | 1982 | 1185 | 0.010 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 1998 | 30 | 0.010 |
Why?
|
Laryngitis | 1 | 1978 | 27 | 0.010 |
Why?
|
Neisseria gonorrhoeae | 1 | 2001 | 238 | 0.010 |
Why?
|
Immunity, Active | 1 | 1998 | 60 | 0.010 |
Why?
|
Plasma Cells | 1 | 1982 | 591 | 0.010 |
Why?
|
Mutation | 2 | 2017 | 29786 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 1990 | 1876 | 0.010 |
Why?
|
Catalysis | 1 | 2000 | 761 | 0.010 |
Why?
|
Sex Offenses | 1 | 1983 | 354 | 0.010 |
Why?
|
Bronchoalveolar Lavage | 1 | 1998 | 120 | 0.010 |
Why?
|
RNA, Viral | 1 | 1987 | 2902 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2015 | 63114 | 0.010 |
Why?
|
Influenza B virus | 1 | 1998 | 50 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1986 | 1821 | 0.010 |
Why?
|
Swine | 3 | 1980 | 5917 | 0.010 |
Why?
|
Penicillin G Benzathine | 1 | 1998 | 24 | 0.010 |
Why?
|
Fetal Growth Retardation | 1 | 1982 | 570 | 0.010 |
Why?
|
Lung Transplantation | 1 | 1987 | 1153 | 0.010 |
Why?
|
Therapeutic Irrigation | 1 | 1999 | 301 | 0.010 |
Why?
|
Amiloride | 1 | 1998 | 121 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 1978 | 425 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6622 | 0.010 |
Why?
|
Cholinergic Agents | 1 | 1998 | 93 | 0.010 |
Why?
|
Interleukins | 1 | 2002 | 791 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2015 | 5137 | 0.010 |
Why?
|
Coronavirus Infections | 1 | 1995 | 3133 | 0.010 |
Why?
|
Streptococcus | 1 | 1998 | 197 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2006 | 2232 | 0.010 |
Why?
|
Forced Expiratory Volume | 1 | 2002 | 1743 | 0.010 |
Why?
|
Sepsis | 1 | 1991 | 2593 | 0.010 |
Why?
|
Immunity, Innate | 2 | 1999 | 2958 | 0.010 |
Why?
|
Larynx | 1 | 1981 | 494 | 0.010 |
Why?
|
Chemokines | 1 | 2001 | 970 | 0.010 |
Why?
|
Ion Transport | 1 | 1998 | 320 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4217 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2000 | 1801 | 0.010 |
Why?
|
Severe Combined Immunodeficiency | 1 | 1998 | 223 | 0.010 |
Why?
|
Isoantigens | 1 | 1978 | 567 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1978 | 1420 | 0.010 |
Why?
|
Cell Size | 1 | 1998 | 643 | 0.010 |
Why?
|
Educational Status | 1 | 1983 | 2540 | 0.010 |
Why?
|
Tight Junctions | 1 | 1998 | 311 | 0.010 |
Why?
|
Infant, Newborn, Diseases | 1 | 1981 | 582 | 0.010 |
Why?
|
Injections | 1 | 1978 | 840 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1990 | 4251 | 0.010 |
Why?
|
Illinois | 1 | 1995 | 119 | 0.010 |
Why?
|
Influenza A virus | 1 | 1998 | 456 | 0.010 |
Why?
|
Chromosomes, Bacterial | 1 | 1996 | 282 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 1987 | 8642 | 0.010 |
Why?
|
Cell Division | 1 | 1982 | 4568 | 0.010 |
Why?
|
Cell Polarity | 1 | 1998 | 645 | 0.010 |
Why?
|
Prognosis | 1 | 1995 | 29063 | 0.010 |
Why?
|
Child Abuse | 1 | 1983 | 1030 | 0.010 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 1998 | 329 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2002 | 2007 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 6314 | 0.010 |
Why?
|
False Negative Reactions | 1 | 1995 | 588 | 0.010 |
Why?
|
Bacteria | 1 | 1984 | 2114 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1998 | 1472 | 0.010 |
Why?
|
Heart Transplantation | 1 | 1987 | 3110 | 0.010 |
Why?
|
Contract Services | 1 | 1993 | 94 | 0.010 |
Why?
|
Personnel Turnover | 1 | 1993 | 83 | 0.010 |
Why?
|
Employee Performance Appraisal | 1 | 1993 | 87 | 0.010 |
Why?
|
Cells, Cultured | 3 | 1998 | 19229 | 0.010 |
Why?
|
Mice, SCID | 1 | 1998 | 2716 | 0.010 |
Why?
|
Administration, Intranasal | 1 | 1974 | 446 | 0.010 |
Why?
|
Goats | 1 | 1972 | 171 | 0.010 |
Why?
|
Swine Diseases | 1 | 1972 | 73 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 1986 | 2988 | 0.010 |
Why?
|
Rickettsia Infections | 1 | 1971 | 9 | 0.010 |
Why?
|
Bartonella Infections | 1 | 1971 | 22 | 0.010 |
Why?
|
Retirement | 1 | 1993 | 215 | 0.010 |
Why?
|
Stereotyping | 1 | 1993 | 241 | 0.010 |
Why?
|
Penicillin Resistance | 1 | 1971 | 84 | 0.010 |
Why?
|
Sewage | 1 | 1971 | 40 | 0.010 |
Why?
|
Community-Acquired Infections | 1 | 1995 | 465 | 0.010 |
Why?
|
International Cooperation | 1 | 1998 | 1420 | 0.010 |
Why?
|
Rhinitis | 1 | 1978 | 691 | 0.010 |
Why?
|
Water Microbiology | 1 | 1971 | 117 | 0.010 |
Why?
|
Sterols | 1 | 1990 | 63 | 0.010 |
Why?
|
Administration, Oral | 1 | 1998 | 3913 | 0.010 |
Why?
|
History, 20th Century | 1 | 1998 | 2740 | 0.010 |
Why?
|
Organizational Culture | 1 | 1993 | 510 | 0.010 |
Why?
|
Interleukin-3 | 1 | 1990 | 444 | 0.010 |
Why?
|
4-Quinolones | 1 | 1988 | 25 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16689 | 0.010 |
Why?
|
Pneumonia, Viral | 1 | 1987 | 3240 | 0.010 |
Why?
|
Aged | 2 | 2011 | 163280 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1998 | 6489 | 0.000 |
Why?
|
Delivery of Health Care | 1 | 2006 | 5319 | 0.000 |
Why?
|
Cell Membrane | 2 | 1990 | 3748 | 0.000 |
Why?
|
Protein Binding | 1 | 2000 | 9386 | 0.000 |
Why?
|
Klebsiella | 1 | 1987 | 48 | 0.000 |
Why?
|
Dogs | 1 | 1972 | 3912 | 0.000 |
Why?
|
Mouth | 1 | 1990 | 374 | 0.000 |
Why?
|
Bronchiolitis | 1 | 1993 | 458 | 0.000 |
Why?
|
Influenza, Human | 1 | 1998 | 1479 | 0.000 |
Why?
|
Drug Administration Schedule | 1 | 1995 | 4933 | 0.000 |
Why?
|
Cecum | 1 | 1987 | 237 | 0.000 |
Why?
|
Biopsy | 1 | 1998 | 6756 | 0.000 |
Why?
|
Epithelial Cells | 1 | 1998 | 3690 | 0.000 |
Why?
|
Disease Outbreaks | 1 | 1995 | 1772 | 0.000 |
Why?
|
Young Adult | 1 | 2011 | 56430 | 0.000 |
Why?
|
Immune Adherence Reaction | 1 | 1984 | 32 | 0.000 |
Why?
|
Serologic Tests | 1 | 1986 | 374 | 0.000 |
Why?
|
Horses | 1 | 1984 | 304 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2000 | 9648 | 0.000 |
Why?
|
Patient Selection | 1 | 1995 | 4215 | 0.000 |
Why?
|
Interferons | 2 | 1980 | 706 | 0.000 |
Why?
|
Sodium Chloride | 1 | 1984 | 625 | 0.000 |
Why?
|
Sialic Acids | 1 | 1981 | 127 | 0.000 |
Why?
|
Perissodactyla | 1 | 1980 | 7 | 0.000 |
Why?
|
Cell Line | 2 | 1989 | 15997 | 0.000 |
Why?
|
Chemical Precipitation | 1 | 1980 | 179 | 0.000 |
Why?
|
Leukemia Virus, Murine | 1 | 1978 | 117 | 0.000 |
Why?
|
H-2 Antigens | 1 | 1978 | 366 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 1995 | 15540 | 0.000 |
Why?
|
Recurrence | 1 | 1987 | 8340 | 0.000 |
Why?
|
Antigens, Viral | 1 | 1978 | 1035 | 0.000 |
Why?
|
Mice, Nude | 1 | 1980 | 3689 | 0.000 |
Why?
|
Heterozygote | 1 | 1980 | 2804 | 0.000 |
Why?
|
Binding Sites | 1 | 1981 | 6114 | 0.000 |
Why?
|
Murine hepatitis virus | 1 | 1971 | 20 | 0.000 |
Why?
|
Mononuclear Phagocyte System | 1 | 1971 | 56 | 0.000 |
Why?
|
Streptomycin | 1 | 1971 | 69 | 0.000 |
Why?
|
Mass Screening | 1 | 1987 | 5255 | 0.000 |
Why?
|
Agar | 1 | 1971 | 56 | 0.000 |
Why?
|
Lactose | 1 | 1971 | 95 | 0.000 |
Why?
|
Ampicillin | 1 | 1971 | 139 | 0.000 |
Why?
|
Toxicology | 1 | 1971 | 106 | 0.000 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 1971 | 132 | 0.000 |
Why?
|
Fermentation | 1 | 1971 | 144 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 1987 | 13989 | 0.000 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1971 | 424 | 0.000 |
Why?
|
Glycoproteins | 1 | 1978 | 2263 | 0.000 |
Why?
|
Enterobacteriaceae | 1 | 1971 | 169 | 0.000 |
Why?
|
Nutritional Physiological Phenomena | 1 | 1971 | 370 | 0.000 |
Why?
|
Plasmodium | 1 | 1971 | 250 | 0.000 |
Why?
|
Carbon | 1 | 1971 | 687 | 0.000 |
Why?
|
Neoplasm Transplantation | 1 | 1971 | 2085 | 0.000 |
Why?
|
Temperature | 1 | 1971 | 2206 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1971 | 2373 | 0.000 |
Why?
|
Behavior, Animal | 1 | 1971 | 1881 | 0.000 |
Why?
|
Antibodies | 1 | 1971 | 2460 | 0.000 |
Why?
|